Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

青少年和年轻人 (AYA) 癌症的临床护理差距和未满足的需求

基本信息

  • 批准号:
    10658891
  • 负责人:
  • 金额:
    $ 116.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-15 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of this population of individuals are understudied despite their unique needs. Unlike younger and older populations, individuals in the AYA age range go through major life transitions, from moving out of the childhood home and seeking employment or higher education, to establishing a career and family. A cancer diagnosis in the context of these life transitions presents challenges that are unique or particularly acute. In the healthcare context, AYAs may lack of continuity of care as they transition from pediatric or adolescent specialists to adult specialists. Fertility preservation strategies are unique to cancer patients diagnosed as AYAs, as recommended options are available only after puberty and through child-bearing age. As many AYAs are at the early stages of their careers, financial concerns are exacerbated with a cancer diagnosis and its treatment, and care may be fragmented across varying providers. Thus, for AYAs, coordination of care for cancer and other conditions may be suboptimal, influencing late effects of the cancer or its treatment, and neglecting the concerns of AYA cancer survivors. We propose three projects, aligned along the cancer care continuum, to improve our knowledge about the best care for AYA cancer survivors. Project 1 focuses on fertility concerns and use of reproductive health services and their impact on cancer treatment. Project 2 focuses on care transitions from active cancer treatment to surveillance and ancillary services in the period 2 to 5 years after diagnosis. Project 3 documents medical conditions and late effects that occur in AYA cancer survivors and identifies factors that influence likelihood of developing these conditions. Each project aims to determine the best approaches to care in their area of focus, to improve outcomes and better address patient needs. These projects are supported by three cores, an Administrative Core, a Biostatistics and Data Harmonization Shared Resource, and a Survey Shared Resource. Population and data resources in this P01 include: the University of North Carolina Cancer Information & Population Health Resource with a state cancer registry linked to health claims; the California Cancer Registry linked to statewide hospitalization, emergency department, and ambulatory surgery data; the Utah Population Database with data similar to that from California; and the integrated healthcare settings of Kaiser Permanente Northern and Southern California. These data provide the opportunity to examine care from multiple providers in varied settings and will be complemented by a survey of 5,000 AYA cancer patients to include patient perspectives as we address our research goals. The multidisciplinary, collaborative research team includes epidemiologists, health services researchers, biostatisticians, pediatric and adult oncologists, and AYA cancer survivors. This research will advance knowledge to improve the care and outcomes of AYA cancer patients and survivors.
摘要-P01,Aya癌症幸存者的临床护理差距和未满足的需求 这项研究计划的重点是癌症护理和诊断为癌症患者的结果。 在青少年和青壮年(Aya)年龄范围内,从15岁到39岁不等。临床护理和长期- 对这一群体的长期监测研究不足,尽管他们有独特的需求。与杨格不同 而老年人,在Aya年龄范围内的个人经历了重大的人生转变,从搬出 从儿时的家和寻求就业或高等教育,到建立事业和家庭。一个 这些生命转变背景下的癌症诊断提出了独特的或特别的挑战 急性期。在医疗保健方面,AYA在从儿科或非儿科过渡时可能缺乏连续性护理 从青少年专家到成人专家。保留生育能力的策略是癌症患者独有的 被诊断为AYA,因为建议的选择只有在青春期后和育龄阶段才可用。 由于许多AYA正处于职业生涯的早期阶段,对财务的担忧因癌症而加剧 诊断及其治疗和护理可能在不同的提供者之间分散。因此,对于AYAS来说, 癌症和其他疾病的护理协调可能不是最理想的,这会影响癌症的后期效应 或者它的治疗,而忽视了Aya癌症幸存者的担忧。我们提出了三个项目,保持一致 沿着癌症护理连续体,提高我们对Aya癌症幸存者最佳护理的知识。 项目1侧重于生育问题和生殖健康服务的使用及其对癌症的影响 治疗。项目2侧重于从积极的癌症治疗到监测和辅助治疗的护理过渡 在确诊后的2至5年内提供服务。项目3记录医疗状况和后遗症 并确定了影响发生这些疾病的可能性的因素 条件。每个项目都旨在确定其重点领域内的最佳护理方法,以改进 结果,并更好地满足患者需求。这些项目由三个核心支持,一个管理 CORE,生物统计和数据协调共享资源,以及调查共享资源。人口 P01中的数据资源包括:北卡罗来纳大学癌症信息与人口 与健康声明链接的州癌症注册的健康资源;加州癌症注册链接到 全州住院、急诊科和门诊手术数据;犹他州人口数据库 与加利福尼亚州的数据相似;以及Kaiser Permanente Northern的综合医疗保健设置 和南加州。这些数据提供了检查来自多个不同提供者的护理的机会 此外,还将对5,000名Aya癌症患者进行调查,将患者的观点包括在内 我们致力于我们的研究目标。这个多学科的合作研究团队包括流行病学家, 卫生服务研究人员、生物统计学家、儿科和成人肿瘤学家以及Aya癌症幸存者。这 研究将促进知识的进步,以改善Aya癌症患者和幸存者的护理和预后。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young Adults.
减少年轻人癌症负担的流行病学研究的挑战和机遇。
  • DOI:
    10.1007/s40471-022-00286-9
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Nichols,HazelB;Wernli,KarenJ;Chawla,Neetu;O'Meara,EllenS;Gray,MarlaineFigueroa;Green,LauraE;Baggett,ChristopherD;Casperson,Mallory;Chao,Chun;Jones,SaleneMW;Kirchhoff,AnneC;Kuo,Tzy-Mey;Lee,Catherine;Malogolowkin,Marcio;
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica Chubak其他文献

Jessica Chubak的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessica Chubak', 18)}}的其他基金

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
青少年和年轻人 (AYA) 癌症的临床护理差距和未满足的需求
  • 批准号:
    10477003
  • 财政年份:
    2020
  • 资助金额:
    $ 116.71万
  • 项目类别:
Core C: Survey Shared Resource Core
核心 C:调查共享资源核心
  • 批准号:
    10658915
  • 财政年份:
    2020
  • 资助金额:
    $ 116.71万
  • 项目类别:
Core C: Survey Shared Resource Core
核心 C:调查共享资源核心
  • 批准号:
    10477025
  • 财政年份:
    2020
  • 资助金额:
    $ 116.71万
  • 项目类别:
Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
青少年和年轻人 (AYA) 癌症的临床护理差距和未满足的需求
  • 批准号:
    10263878
  • 财政年份:
    2020
  • 资助金额:
    $ 116.71万
  • 项目类别:
Core C: Survey Shared Resource Core
核心 C:调查共享资源核心
  • 批准号:
    10263885
  • 财政年份:
    2020
  • 资助金额:
    $ 116.71万
  • 项目类别:
Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
不同环境下宫颈癌筛查流程的多层次优化
  • 批准号:
    10600841
  • 财政年份:
    2018
  • 资助金额:
    $ 116.71万
  • 项目类别:
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
ReCAPSE:SEER 增强的索赔和 PRO 的复发
  • 批准号:
    10428568
  • 财政年份:
    2017
  • 资助金额:
    $ 116.71万
  • 项目类别:
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
ReCAPSE:SEER 增强的索赔和 PRO 的复发
  • 批准号:
    10601364
  • 财政年份:
    2017
  • 资助金额:
    $ 116.71万
  • 项目类别:
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
ReCAPSE:SEER 增强的索赔和 PRO 的复发
  • 批准号:
    10202500
  • 财政年份:
    2017
  • 资助金额:
    $ 116.71万
  • 项目类别:
Psychological benefits and potential pathogen transmission in hospitalized pediatric oncology patients receiving therapy dog visits: a randomized controlled trial
接受治疗犬就诊的住院儿科肿瘤患者的心理益处和潜在病原体传播:一项随机对照试验
  • 批准号:
    9322093
  • 财政年份:
    2017
  • 资助金额:
    $ 116.71万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 116.71万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了